AVI-4020 Uses, Dosage, Side Effects and more
AVI-4020 is a neugene antisense drug candidate for the treatment of patients with acute West Nile virus disease who have serious neurological impairment (WNV neuroinvasive disease).
| Trade Name | AVI-4020 |
| Generic | AVI-4020 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in infectious and parasitic disease (unspecified) and viral infection.
How AVI-4020 works
AVI-4020 has rapid response therapeutics that plays a significant role in the future of antiviral therapeutics, especially in combating emerging infectious diseases that threaten public health or in combating bioterrorism.
